Lipid-based nanocarriers for siRNA delivery: challenges, strategies and the lessons learned from the DODAX: MO liposomal system
ACN Oliveira, J Fernandes, A Gonçalves… - Current drug …, 2019 - ingentaconnect.com
The possibility of using the RNA interference (RNAi) mechanisms in gene therapy was one
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
[PDF][PDF] Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
ACN Oliveira, J Fernandes, A Gonçalves… - Current Drug …, 2018 - core.ac.uk
The possibility of using the RNA interference (RNAi) mechanisms in gene therapy was one
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
ACN Oliveira, J Fernandes, A Gonçalves… - Current drug …, 2019 - pubmed.ncbi.nlm.nih.gov
The possibility of using the RNA interference (RNAi) mechanisms in gene therapy was one
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
ACN Oliveira, J Fernandes, A Gonçalves… - Current Drug …, 2019 - europepmc.org
The possibility of using the RNA interference (RNAi) mechanisms in gene therapy was one
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …
of the scientific breakthroughs of the last century. Despite the extraordinary therapeutic …